You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

Article metrics

Article menu

Download PDFPDF

XML
Coronary artery disease
Original research article
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

 

Online download statistics by month:

Online download statistics by month: September 2018 to March 2024

AbstractFullPdf
Sep 201811311425
Oct 201819619535
Nov 2018697025
Dec 2018525224
Jan 2019575621
Feb 2019494914
Mar 2019474616
Apr 2019464514
May 2019323217
Jun 201927266
Jul 2019303016
Aug 201923236
Sep 201924242
Oct 201936367
Nov 201919195
Dec 201926257
Jan 2020242411
Feb 202041391
Mar 202030309
Apr 202018188
May 202020207
Jun 202030309
Jul 202024246
Aug 202013133
Sep 2020413815
Oct 202023215
Nov 202028278
Dec 202029297
Jan 2021454217
Feb 202129258
Mar 202117173
Apr 2021312810
May 202124227
Jun 202117174
Jul 202119198
Aug 2021282717
Sep 202128288
Oct 2021242422
Nov 2021161417
Dec 202127259
Jan 202214143
Feb 2022151812
Mar 2022252414
Apr 2022404720
May 2022272916
Jun 20221296
Jul 202212125
Aug 2022161511
Sep 2022141426
Oct 20225485469
Nov 202220219913
Dec 2022414214
Jan 2023666517
Feb 202371729
Mar 2023313211
Apr 202339359
May 202348485
Jun 202328266
Jul 2023484518
Aug 202320209
Sep 202321202
Oct 202326256
Nov 202329286
Dec 202333299
Jan 202422224
Feb 202428266
Mar 202420147
Total29682919732